Skip to main content
OpenTrials
Completed

NCT Number: NCT05493020

The Association Between Watching Mukbang Videos and the Appetite of Children With Cancer

The purpose of this study is to record the "Mukbang" watching behavior and appetite of children with cancer during inpatient radiotherapy and chemotherapy through intensive longitudinal study, explore their correlation, and the impact on their nutritional status and quality of life, and formulate for clinical departments relevant interventions and management options provide a theoretical basis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

XIAW

Guangzhou, Guangdong, 510080, China

About this study

World Health Organization(WHO) data shows that the prevalence of malnutrition in children with cancer is as high as 75%, which leads to decreased immune function in children with cancer, unsatisfactory treatment effect, increased adverse clinical outcomes, early tumor recurrence, prolonged recovery time, and death. risk factors such as increased rates. The "Global Childhood Oncology Initiative" proposed by WHO in 2020 pointed out that reducing hunger and malnutrition and improving the outcomes of children with cancer are one of the main tasks of providing best practices in pediatric oncology care.

The excessive consumption of the body caused by the cachexia of the tumor itself cannot be changed. Nutritional intake is the only adjustable factor for malnutrition in children with tumors. Loss of appetite is the main reason for insufficient nutritional intake. Numerous clinical studies have explored the nutritional management of children with cancer. However, most nutritional interventions are ineffective due to poor appetite and food intake in children.

The investigation in the clinical ward found that in order to cope with the problem of loss of appetite, many children with cancer took the initiative to watch "Mukbang" during hospitalization to relieve gastrointestinal symptoms and increase appetite. At present, studies have shown that "Mukbang" may have the potential to improve the appetite of children with tumors. In addition, watching "Mukbang" is a way that children actively choose to increase their appetite, which has better acceptability.

Intensive longitudinal study can explain the dynamic changes of children's behavior and appetite when watching "Mukbang" videos by sampling in a natural context for a short period of time and multiple times, and based on real-time data, further Explain in detail the persistent effect of watching "Mukbang" video behaviors on appetite.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 3-18;
  • Children who conform to the Notice on Printing and Distributing the Diagnosis and Treatment Specifications for 12 Diseases Related to Hematological Diseases and Malignancies in Children (2021 Edition) issued by the General Office of the National Health and Health Commission;
  • Experienced at least one complete cycle of chemotherapy and radiotherapy.

Exclusion criteria

  • Children with severe cardiopulmonary disease, severe infection, severe organ damage, genetic metabolic disease, immunodeficiency disease or mental illness;
  • Children with eye and ear dysfunction at the same time, resulting in the inability to watch and listen to videos.

Treatment and study plan

Questionnaires set

Other

At baseline, the children's demographics, disease-related data, characteristics of "Mukbang"watching behavior, appetite, nutritional status, and quality of life data were collected. From the first day of radiotherapy or chemotherapy, 3 meals a day for 5 consecutive days were followed to track the children's appetite status and the characteristics of "Mukbang"watching behavior. Their nutritional status and quality of life were tracked at the end of treatment or when they were discharged from the hospital.

Primary outcomes

  1. Appetite

    Time frame: Appetite change over 5 days during chemoradiotherapy from baseline

    The appetite will be assessed by Cancer Appetite and Symptom Questionnaire(CASQ) . The questionnaire consisted of 12 items, each item ranged from 0 to 4 points, and the total score of the questionnaire ranged from 0 to 48 points. The lower the total score, the worse the patient's appetite.

  2. Mukbang Watching Features

    Time frame: Mukbang Watching Features change over 5 days during chemoradiotherapy from baseline

    The "Mukbang" watching features will be assessed by a questionnaire designed by the researcher and recorded by the subjects themselves, including watching time, watching rate, watching preferences and watching experience.

Secondary outcomes

  1. Nutritional status

    Time frame: Change in nutritional status over 7 days from baseline

    The nutritional status will be assessed by using the Subjective Global Nutritional Assessment(SGNA). Assessment included the children's recent height, weight, parental height, dietary intake, changes in appetite, frequency and duration of gastrointestinal symptoms, and recent physical activity and changes. This provides a comprehensive assessment of the nutritional status of children, with ratings classified as well-nourished, moderately malnourished or severely malnourished.

  2. Quality of Life in children with cancer

    Time frame: Change in quality of life over 7 days from baseline

    The quality of life in children with cancer will be assessed by using the Pediatric Quality of Life Inventory Measurement Models 3.0(PedsQLTM-3.0-cancer).The model has a total of 27 items, including 8 subscales, each item used a 5-point Likert scale, (0=never, 1=almost never, 2=sometimes, 3=often, 4 = almost always), higher scores indicate better quality of life.

Sponsors and collaborators

Lead sponsor

Sun Yat-sen University

Other

Registry information

Official study title

The Association of Mukbang Watching Behavior and the Appetite of Children With Cancer Hospitalized for Radiotherapy and Chemotherapy: An Intensive Longitudinal Study

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Aug 9, 2022
Registry last updated
Apr 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.